Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
Pan, Chen, Zhang et al. investigated the anti-cancer efficacy of CA170, a small molecule agonist of VISTA, on mouse lung tumorigenesis. When combined with a MHCII-directed KRAS peptide vaccine, the authors reported that CA170 suppressed lung tumor development by increasing CD8+ T cell and decreasing...
Enregistré dans:
Auteurs principaux: | Jing Pan, Yao Chen, Qi Zhang, Achia Khatun, Katie Palen, Gang Xin, Li Wang, Chuanjia Yang, Bryon D. Johnson, Charles R. Myers, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Weiguo Cui, Ming You |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/25463f045f454089abc25f6e7b64cc74 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
par: Pottayil G. Sasikumar, et autres
Publié: (2021) -
Explosive eruption, flank collapse and megatsunami at Tenerife ca. 170 ka
par: Raphaël Paris, et autres
Publié: (2017) -
Acta Nº170
par: Banco Central de Chile
Publié: (2019) -
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
par: Na Li, et autres
Publié: (2017) -
The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
par: Amina Ghouzlani, et autres
Publié: (2021)